• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Feinstein Predicts Youth Impulsivity From Brain Data

    BUSINESSWIRE

    Global Study From Feinstein Institutes To Unlock Secrets

    BUSSINESSWIRE

    Four Feinstein Scientists Named NAI Senior Members

    BUSINESSWIRE

    Feinstein Institutes` Kevin J. Tracey Named To TIME100 2026

    BUSINESSWIRE

    Feinstein Institutes` Dr. Stephanie Fitzpatrick Elected Fellow

    BUSINESSWIRE

    NAI Elects Feinstein`s Dr. Kevin J. Tracey to 2025 Fellows

    BUSINESSWIRE

    Feinstein Institutes Find Metabolic Pathway for Septic Survival

    BUSINESSWIRE

    Feinstein Institutes Dr Douglas Nixon Named IDSA Fellow

    BUSINESSWIRE

    Feinstein Institutes Explore Bioelectronics for Insulin Use

    BUSINESSWIRE

    Feinstein Institutes Research: New Vagus Nerve Stimulation Method

    BUSINESSWIRE

    Feinstein Institutes 2025 Ross Prize goes to Dr. Jeffery W. Kelly

    BUSINESSWIRE

    Feinstein Institutes Study Vagus Nerve Stimulation for Obesity

    BUSINESSWIRE

    Feinstein Finds Vagus Nerve Encodes Immune Signals

    BUSINESSWIRE

    Feinstein Research Shows Cancer Drugs Could Aid Vascular Disease

    BUSINESSWIRE

    Feinstein Institutes Suggests New Protocols For Oral Anticoagulant Patients

    BUSINESSWIRE

    Vagus Nerve Splenic Activation Shows Promise for Infections

    BUSINESSWIRE

    Garden City HS Wins Feinstein Science Competition

    BUSINESSWIRE

    Feinstein Institutes’ Study Discovers That Mitochondrial Transplantation Improves Survival and Outcomes After Cardiac Arrest

    BUSINESSWIRE

    Feinstein Institutes report on mapping of vagus nerve, unveil novel stimulator

    BUSINESSWIRE

    Feinstein Institutes researcher discovers therapeutic target for lethal sepsis

    BUSINESSWIRE

    Feinstein Institutes lupus researchers recognized with top honors

    BUSINESSWIRE

    Feinstein Institutes Awarded $2.5M From NIH to Study Sepsis Drug Targets

    BUSINESSWIRE

    Montefiore and Einstein assess remdesivir and baricitinib for Covid-19

    CLINICALTRIALSARENA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.